Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. CARE Group.

@article{Freedberg2001RecurrenceOS,
  title={Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. CARE Group.},
  author={Nachum Adam Freedberg and John N Hill and Richard Ira Fogel and Eric N. Prystowsky},
  journal={Journal of the American College of Cardiology},
  year={2001},
  volume={37 7},
  pages={1910-5}
}
OBJECTIVES The purpose of this study was to investigate whether clinical or electrophysiologic characteristics could predict initial and subsequent implantable cardioverter defibrillator (ICD) therapy. BACKGROUND Identification of markers to predict subsequent ICD therapy and symptoms after the first event could affect patient management. METHODS We… CONTINUE READING